| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |